We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Diagnostic Methods Compared for Detection of Malaria

By LabMedica International staff writers
Posted on 04 Oct 2018
Print article
Image: The NADAL Malaria 4 species test (RDT) (Photo courtesy of Nal von Minden).
Image: The NADAL Malaria 4 species test (RDT) (Photo courtesy of Nal von Minden).
The main strategy for malaria control is quick and accurate diagnosis followed by effective treatment. The early and accurate diagnosis of malaria is essential for both effective disease management and malaria surveillance.

Microscopy is still considered the “gold standard” for malaria diagnosis in endemic countries, but microscopy has low sensitivity when performed by poorly trained personnel in endemic areas, especially in primary and secondary healthcare facilities. Rapid detection tests (RDTs) for malaria are widespread but constrained by false results, while polymerase chain reaction (PCR) is the most sensitive method available is it not appropriate for field use.

Tropical medicine specialists at the Institute of Health Carlos III (Madrid, Spain) and their colleagues recruited a total of 1,741 individuals; 1,043 and 698 people living in urban and rural settings, respectively, living in Equatorial Guinea. Blood samples were taken from the finger for the diagnosis of malaria using malaria RDTs and microscopy. The blood was spotted on Whatman 903 paper for further molecular studies.

The NADAL Malaria 4 species test (Test cassette) was used as the RDT in situ. The test enables differential diagnosis between Plasmodium malariae, P. falciparum, P. vivax, and P. ovale in human whole blood samples. Semi-nested multiplex PCR (SnM-PCR) was performed after the DNA was extracted from the filter papers. The SnM-PCR used in this study for the diagnosis of malaria has a sensitivity of 0.0001 parasites/μL.

The team reported that among the negative samples detected by microscopy, 335 (19.4%) were false negatives. On the other hand, the negative samples detected by RDT, 128 (13.3%) were false negatives based on PCR. This finding is important, especially since it is a group of patients who did not receive antimalarial treatment. RDT showed higher sensitivity than microscopy in all age groups. Both diagnostic tools showed higher sensitivity in children aged 13 months to 5 years, decreasing as age increase. RDTs also showed higher specificity than microscopy in all age groups, being both techniques more specific in children under 12 months of age and above 15 years old.

The authors concluded although RDTs are used as diagnostic methods, diagnosis by microscopy should never be abandoned because it is the gold standard in endemic areas. In addition, microscopy allows the calculation of parasitic densities and identification of all species and is cheaper than the other methods. Although it is the best diagnostic method with high sensitivity and specificity, PCR is still costly and not very useful for routine diagnosis. The study was published on September 17, 2018, in the Malaria Journal.

Related Links:
Institute of Health Carlos III

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.